CANAAN X L.P. Insider Trading
Get free email notifications about insider trading for CANAAN X L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CANAAN X L.P.. CANAAN X L.P. is a 10% Owner in Protagonist Therapeutics, Inc ($PTGX) and a Director in Protagonist Therapeutics, Inc ($PTGX) and a Director in Iterum Therapeutics plc ($ITRM) and a 10% Owner in NextCure, Inc. ($NXTC) and a 10% Owner in IDEAYA Biosciences, Inc. ($IDYA).
Address: 285 RIVERSIDE AVENUE, SUITE 250 WESTPORT 06880 CT
Companies in which CANAAN X L.P. is an Insider
IDEAYA Biosciences, Inc.
Trading Symbol: IDYAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CANAAN X L.P.: 10% Owner
Holdings: 1,658,164 shares
Latest Transaction: May 28 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Iterum Therapeutics plc
Trading Symbol: ITRMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CANAAN X L.P.: Director
Holdings: 721,408 shares
Latest Transaction: May 30 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NextCure, Inc.
Trading Symbol: NXTCIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CANAAN X L.P.: 10% Owner
Holdings: 445,866 shares
Latest Transaction: May 13 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Protagonist Therapeutics, Inc
Trading Symbol: PTGXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CANAAN X L.P.: 10% Owner, Director
Holdings: 2,116,552 shares
Current Value: $37,886,281
Latest Transaction: May 21 2018
$PTGX Market Capitalization: $282.80M
$PTGX Previous Close: $17.90
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of CANAAN X L.P.
Sentiment: All, IDYA, ITRM, NXTC, PTGX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 28 2019 | IDYA | IDEAYA Biosciences ... | CANAAN X L.P. | 10% Owner | Option Exercise | C | 0.00 | 602,549 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | CANAAN X L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,658,164 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | CANAAN X L.P. | 10% Owner | Buy | P | 10.00 | 400,000 | 4,000,000 | 2,660,713 | 2.3 M to 2.7 M (+17.69 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | CANAAN X L.P. | 10% Owner | Buy | C | 0.00 | 602,549 | 0 | 2,260,713 | 1.7 M to 2.3 M (+36.34 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | CANAAN X L.P. | 10% Owner | Buy | C | 0.00 | 1,658,164 | 0 | 1,658,164 | 0 to 1.7 M |
May 13 2019 | NXTC | NextCure, Inc. | CANAAN X L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,296,605 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | CANAAN X L.P. | 10% Owner | Option Exercise | C | 0.00 | 5,861,455 | 0 | 0 |